COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 07:00, il y a 4 mois 30 jours Swiss Prime Site Solutions Investment Fund Commercial (« SPSS IFC ») : cotation réussie à la SIX Swiss Exchange Le fonds immobilier commercial SPSS IFC fait une cotation réussie à la SIX Swiss Exchange, offrant aux investisseurs des immeubles commerciaux suisses à haut rendement Investisseurs SIX Swiss Exchange Cotation SPSS IFC Immeubles Commerciaux
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 07:00, il y a 4 mois 30 jours Swiss Prime Site Solutions Investment Fund Commercial («SPSS IFC»): successful listing on the SIX Swiss Exchange Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) successfully listed on the SIX Swiss Exchange, reaching CHF 500M market value with a selective growth strategy for high-yield properties Swiss Prime Site Solutions Commercial Real Estate SIX Swiss Exchange Investment Fund SPSS IFC
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 07:00, il y a 4 mois 30 jours PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet Growing Demand for Peptide Supply in Metabolic Therapies PolyPeptide and Lupin Manufacturing Solutions form alliance to enhance peptide supply for metabolic therapies, ensuring agility and quality Alliance PolyPeptide Peptide Supply Metabolic Therapies Lupin Manufacturing Solutions
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 06:45, il y a 4 mois 30 jours Leclanché SA Strengthens its Capital Structure through Debt-to-Equity Conversion Leclanché SA strengthens its capital structure through CHF 40.06 million debt-to-equity conversion, reinforcing financial position and supporting strategic growth initiatives Strategic Growth Capital Structure Financial Resilience Leclanché SA Debt-to-equity Conversion
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 06:45, il y a 4 mois 30 jours Leclanché SA renforce sa structure financière grâce à une conversion de dette en capital Leclanché SA renforce sa structure financière grâce à une conversion de dette en capital. La conversion de dette en capital renforce le bilan de l'entreprise et soutient la croissance Bilan Financier Croissance Stratégique Conversion De Dette Leclanché SA Restructuration Du Capital
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 05:45, il y a 4 mois 30 jours CGTN: How does China set tone for economic work in 2026? CGTN article highlights China's 2026 economic agenda focusing on domestic demand, innovation, and opening-up, signaling confidence for global development China Global Development 2026 CGTN Economic Agenda
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 04:00, il y a 4 mois 30 jours World-leading Economists and Thought Leaders Converge at Hong Kong’s Landmark Forum to Decode China’s Economic Future in a Multipolar World The International Forum on China's Economy and Policy 2025, organized by the CEPU of HKSAR Government, convened global experts to discuss economic transformations and Hong Kong's role in the evolving landscape Hong Kong Global Economy International Forum China's Economy CEPU
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 00:20, il y a 4 mois 30 jours Now Is Yours: Huawei Rolls Out Mate X7 Alongside a New Lineup of Innovative Products Huawei unveils Mate X7 smartphone, FreeClip 2 earphones, WATCH ULTIMATE DESIGN smartwatch, and MatePad 11.5 S tablet at launch event themed 'Unfold the Moment', focusing on innovative products and user-centric design Huawei Mate X7 FreeClip 2 WATCH ULTIMATE DESIGN MatePad 11.5 S
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 00:05, il y a 4 mois 30 jours NOTICE OF SETTLEMENT APPROVAL ITHACA ENERGY INC. now known as ITHACA ENERGY LIMITED SECURITIES CLASS ACTION SECURITIES CLASS ACTION Notice of settlement approval for Ithaca Energy Inc. in securities class action. Class action settlement approved by Alberta Court of King's Bench. Class members must submit Claim Form by January 5, 2026, for compensation Securities Class Action Settlement Approval Ithaca Energy Inc. Alberta Court Of King's Bench Claim Form
COMMUNIQUÉ DE PRESSE publié le 12/12/2025 à 00:00, il y a 4 mois 30 jours LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies LIR Life Sciences files provisional patent for needle-free delivery platform for GLP/GIP therapies in obesity and metabolic diseases, aiming to improve treatment accessibility and adherence Metabolic Diseases Obesity Provisional Patent GLP/GIP Therapies LIR Life Sciences
Publié le 11/05/2026 à 17:47, il y a 13 minutes Déclaration des transactions sur actions propres réalisées du 04/05/2026 au 10/05/2026
Publié le 11/05/2026 à 17:45, il y a 16 minutes Annule et remplace : Informations relatives au nombre total de droits de vote et d’actions
Publié le 11/05/2026 à 14:30, il y a 3 heures 31 minutes Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Publié le 11/05/2026 à 14:00, il y a 4 heures 1 minute Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Publié le 11/05/2026 à 14:00, il y a 4 heures 1 minute New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Publié le 11/05/2026 à 14:00, il y a 4 heures 1 minute Colosseum Bankable Feasibility Study Confirms High Margin Gold Project
Publié le 11/05/2026 à 14:00, il y a 4 heures 1 minute Ur-Energy Reminds Shareholders and Interested Parties of First Quarter Conference Call and Webcast
Publié le 11/05/2026 à 17:53, il y a 8 minutes EQS-Adhoc: EnviTec Biogas issues forecast: Subdued earnings development in the current fiscal year 2026, top-line and earnings growth in 2027; Suspension of dividend for 2025 proposed
Publié le 11/05/2026 à 17:48, il y a 12 minutes Elmos Semiconductor SE: Placement of existing shares by two major Elmos shareholders via accelerated bookbuilding
Publié le 11/05/2026 à 17:40, il y a 21 minutes EQS-Adhoc: Elmos Semiconductor SE: Placement of existing shares by two major Elmos shareholders via accelerated bookbuilding
Publié le 11/05/2026 à 17:40, il y a 21 minutes VALBIOTIS SA: Valbiotis continues its expansion in Asia